Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway

Ke Si Wang1, Ying Lv1, Zhe Wang1

  • 1Key Laboratory of Natural Resources of Changbai Mountain and Functional Molecules, Ministry of Education, Molecular Medicine Research Center, College of Pharmacy, Yanbian University, Yanbian, Jilin 133002, P.R. China.

Oncology Reports
|April 26, 2017
PubMed

Insights

Imperatorin, derived from Angelica dahurica, effectively reduces inflammation by inhibiting key pathways like NF-κB and PI3K/Akt. This natural compound shows promise in combating cancer-related inflammation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Inflammation is a key driver in cancer development and progression, particularly in cervical cancer.
  • Cervical cancer remains a significant global health issue for women worldwide.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of imperatorin, a compound from Angelica dahurica.
  • To elucidate the molecular mechanisms by which imperatorin modulates inflammatory responses in cancer cells.

Main Methods:

  • Utilized HeLa cells stimulated with tumor necrosis factor-alpha (TNF-α).
  • Assessed the impact of imperatorin on cytokine production and expression.
  • Analyzed key signal-transduction pathways including NF-κB and PI3K/Akt.
  • Measured reactive oxygen species (ROS) generation.

Main Results:

  • Imperatorin significantly inhibited TNF-α-induced expression of NF-κB target genes (COX-2, cyclin D1, MMP-9, VEGF, IL-6, Bcl-xL).
  • Imperatorin suppressed NF-κB activation by inhibiting IKKα/β and IκB phosphorylation, and NF-κB p65 nuclear translocation.
  • Imperatorin downregulated TNF-α-induced PI3K/Akt activation and inhibited ROS generation.

Conclusions:

  • Imperatorin exhibits potent anti-inflammatory properties against TNF-α stimulation in cancer cells.
  • The anti-inflammatory action of imperatorin is mediated through the inhibition of ROS-dependent PI3K/Akt/NF-κB signaling.
  • Imperatorin represents a potential therapeutic agent for managing inflammation in cancer.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
664
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K